Opioid Use Disorder

Patients who attended a Pennsylvania hospital ED implementing a financial incentive program to increase opioid use disorder treatment engagement were more likely to start buprenorphine compared with patients at other hospitals.

A medication-assisted treatment, or MAT, supplemental training program improved primary care physicians’ confidence and willingness to implement MAT for opioid use disorder, a recent study found.

In addition to a financial incentive, bupropion may help some people being treated for opioid use disorder to stop using cocaine, according to findings published in JAMA Network Open.

Participation in an outreach program following a nonfatal opioid overdose was associated with lower risk for later overdose death, according to data published in JAMA Psychiatry.

Among Medicaid beneficiaries with opioid use disorder, those with a disability were less likely to receive medication treatment and to adhere to treatment for 6 months, according to findings published in JAMA Network Open.

Artificial intelligence models may help develop drugs that can help people overcome opioid use disorder, according to findings presented at the Biophysical Society Annual Meeting.

A digital therapeutic software company has expanded its collaboration with an outpatient addiction treatment provider to provide adults with substance use disorder and opioid use disorder access to prescription digital therapeutics.

The proportion of buprenorphine-involved overdose deaths did not significantly increase after prescribing flexibilities were introduced in the beginning of the COVID-19 pandemic, according to recent findings published in JAMA Network Open.

Telehealth was a comparable alternative to in-person care for opioid use disorder during the COVID-19 pandemic, indicating that telehealth can safely be used to expand access to this care, according to researchers.

The FDA has accepted and granted priority review to Purdue Pharma’s abbreviated new drug application for the opioid antagonist nalmefene hydrochloride injection 2 mg/2 mL prefilled syringes, the company announced in a press release.